mRNA Biologics Platforms

About Vernagen

Vernagen is a private, preclinical biotech firm founded in 2019 and based in San Francisco, operating in the high-growth RNA and gene therapy sector. The company is developing a proprietary mRNA platform aimed at creating vaccines against infectious diseases and biologics for immunological and genetic disorders. Led by founder and CEO Dr. Baek Kim, an academic virologist at Emory University, the company is currently in the research and preclinical validation stage. As a pre-revenue entity, its success hinges on advancing its platform through proof-of-concept studies and securing strategic partnerships or funding.

Therapeutic Areas